Updated Feb. 26, 2013 at 11:23 a.m.

Premium Lock FDA puts Furiex antibiotic on fast track for review

Published: 2013-02-26 11:16:00
Updated: 2013-02-26 11:23:02

Furiex Furiex

A potential new MRSA treatment being developed by Furiex Pharmaceuticals (NASDAQ: FURX) will get speedier regulatory review from the Food and Drug Administration....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders